Diagnostic Services
Diagnostic solutions
We offer a broad range, from routine tests with reagent-rental systems to advanced oncological analyses with molecular laboratory solutions.

02.1 · Diagnostic services
Reagent-rental pathology laboratory system solutions
- 01
Liquid-Based Cytology (LBC)
Screening solutions that place cells directly into fixative liquid, remove blood and mucus, spread them in a thin monolayer and allow reflex HPV DNA testing from the same specimen.
- 02
Hematoxylin & Eosin (H&E)
Staining solutions that form the basis of routine histopathological diagnosis and provide standardized, high-volume tissue staining through automated staining systems.
- 03
Immunohistochemistry (IHC)
Diagnostic testing solutions that make antigen-antibody reactions reproducible and consistent through fully automated systems for tumor subtyping and prognostic marker analysis.
- 04
Histochemistry (HC / Special Stains)
Special staining solutions that selectively demonstrate structures such as microorganisms, mucin and connective tissue while standardizing time and reagent use with automated instruments.
- 05
HPV Genotyping
Molecular diagnostic solutions that detect high-risk genotypes to assess cervical lesion and cancer risk, providing rapid, standardized results with fully automated molecular systems designed to prevent contamination.
02.2 · Diagnostic services
Reagent-rental molecular pathology laboratory system solutions
- 01
Solid Tumors
Molecular testing solutions for targeted gene mutation, amplification and fusion analyses from FFPE tissue blocks to support diagnosis, staging and targeted therapy selection.
- 02
Liquid Biopsy
Complementary analysis solutions that detect resistance mutations and minimal residual disease through circulating tumor DNA (ctDNA) from blood when an FFPE tissue specimen is insufficient or inaccessible.
- 03
Hematology
Molecular diagnostic solutions that detect genetic abnormalities in bone marrow and lymph node FFPE biopsies for leukemia and lymphoma subtyping, clonality assessment and prognosis.
- 04
Comprehensive Genomic Profiling (CGP)
Advanced NGS solutions that simultaneously analyze hundreds of genes from a limited number of FFPE sections to identify immunotherapy and targeted-therapy biomarkers such as TMB and MSI.
- 05
Hereditary Cancers
Genetic screening solutions used to investigate the germline origin of somatic variations in FFPE tissue and confirm familial cancer predisposition genes, such as BRCA1/2 and Lynch syndrome.
Let’s assess your pathology laboratory together.
Talk to our team about analyzing your laboratory, a new setup, digital transformation or full operation.
Contact us
